Rs2853533
From SNPedia
| Orientation | plus |
| is a | snp |
| is | mentioned by |
| dbSNP | rs2853533 |
| PheGenI | rs2853533 |
| nextbio | rs2853533 |
| hapmap | rs2853533 |
| 1000 genomes | rs2853533 |
| hgdp | rs2853533 |
| ensembl | rs2853533 |
| gopubmed | rs2853533 |
| geneview | rs2853533 |
| scholar | rs2853533 |
| rs2853533 | |
| pharmgkb | rs2853533 |
| gwascentral | rs2853533 |
| openSNP | rs2853533 |
| 23andMe | rs2853533 |
| 23andMe all | rs2853533 |
| SNP Nexus | |
| SNPshot | rs2853533 |
| SNPdbe | rs2853533 |
| MSV3d | rs2853533 |
| Gene | C18orf56, TYMS |
| Chromosome | 18 |
| Orientation | plus |
| GMAF | 0.3027 |
| Position | 658064 |
| Reference | GRCh37.p2 37.2/134 |
| Max Magnitude |
| Make rs2853533(C;C) |
| Make rs2853533(C;G) |
| Make rs2853533(G;G) |
| ? | (C;C) (C;G) (G;G) | 28 |
|---|---|---|
[PMID 19339911] Association of thymidylate synthase variants with 5-fluorouracil cytotoxicity.
| GET Evidence | |
|---|---|
| C18ORF56-R62G | |
| aa_change | Arg62Gly |
| aa_change_short | R62G |
| impact | pharmacogenetic |
| qualified_impact | Insufficiently evaluated pharmacogenetic |
| overall_frequency | 0.20487 |
| summary | |
